Immune system activation by natural products and complex fractions: a network pharmacology approach in cancer treatment
Authors:Alejandra Gomez-Cadena1,2,3, Alfonso Barreto3, Susana Fiorentino3 and Camilla Jandus1,2
1 Department of Pathology and Immunology, Targeting of Cytokine Secreting Lymphocyte group, Geneva University, Geneva, Switzerland.
2 Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Switzerland.
3 Departamento de Microbiología, Grupo de Inmunobiología y Biología Celular, Pontificia Universidad Javeriana, Bogotá, Colombia.
Keywords:
natural products, cancer, immune response, network pharmacology, immunomodulation, herbal medicine, immunogenic cell death.
Abbreviations:
CRT – calreticulin;
DAMP – damage associated molecular pattern;
DC – dendritic cell;
DMIM – Distance-based Mutual Information Model;
ER – endoplasmic reticulum;
HCV – hepatitis C virus;
ICD – immunogenic cell death;
JTT – juzen-taiho-to;
NK – natural killer;
NP – network pharmacology;
PDT – photodynamic therapy;
ROS – reactive oxygen species;
SK – shikonin;
TCM – Traditional Chinese Medicine;
UPR – unfolded protein response.
Corresponding Author(s):
Conflict of interest statement:
None of the authors declares any conflict of interest.
Please cite this article as:
Alejandra Gomez-Cadena, Alfonso Barreto, Susana Fiorentino and Camilla Jandus (2020). Immune system activation by natural products and complex fractions: a network pharmacology approach in cancer treatment. Cell Stress 4(7): 154-166. doi: 10.15698/cst2020.07.224
© 2020 Gomez-Cadena <iet al. This is an open-access article released under the terms of the Creative Commons Attribution (CC BY) license, which allows the unrestricted use, distribution, and re-production in any medium, provided the original author and source are acknowledged.
Abstract:
Natural products and traditional herbal medicine are an important source of alternative bioactive compounds but very few plant-based preparations have been scientifically evaluated and validated for their potential as medical treatments. However, a promising field in the current therapies based on plant-derived compounds is the study of their immunomodulation properties and their capacity to activate the immune system to fight against multifactorial diseases like cancer. In this review we discuss how network pharmacology could help to characterize and validate natural single molecules or more complex preparations as promising cancer therapies based on their multitarget capacities.